Fujifilm Diosynth Biotechnologies will use its pAVEway advanced protein expression technology at its Billingham, UK, facility to support the process development and cGMP manufacture of CF-301, ContraFect’s Staphylococcal-specific bacteriophage lysine.
Manufacturing Chemist
Monday 31 October 2011
Fujifilm to manufacture ContraFect biologic
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment